GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Dividend Yield %

Oculis Holding AG (FRA:CR5) Dividend Yield % : 0.00% (As of Jun. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Dividend Yield %?

As of today (2024-06-21), the Trailing Annual Dividend Yield of Oculis Holding AG is 0.00%.

The historical rank and industry rank for Oculis Holding AG's Dividend Yield % or its related term are showing as below:

FRA:CR5's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.635
* Ranked among companies with meaningful Dividend Yield % only.

Oculis Holding AG's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00.

As of today (2024-06-21), the Forward Dividend Yield % of Oculis Holding AG is 0.00%.

Oculis Holding AG's Dividends per Share for the three months ended in Mar. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Oculis Holding AG Dividend Yield % Historical Data

The historical data trend for Oculis Holding AG's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Dividend Yield % Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Dividend Yield %
- - - -

Oculis Holding AG Quarterly Data
Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oculis Holding AG's Dividend Yield %

For the Biotechnology subindustry, Oculis Holding AG's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oculis Holding AG's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's Dividend Yield % falls into.



Oculis Holding AG Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Oculis Holding AG  (FRA:CR5) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Oculis Holding AG Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oculis Holding AG (FRA:CR5) Business Description

Traded in Other Exchanges
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (FRA:CR5) Headlines

No Headlines